|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0036043,
umls-concept:C0241315,
umls-concept:C0376196,
umls-concept:C0376691,
umls-concept:C0524910,
umls-concept:C1096776,
umls-concept:C1555721,
umls-concept:C1706204,
umls-concept:C2347387
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
2008-12-18
|
|
pubmed:abstractText |
Though patients in opiate substitution programs are commonly infected with HCV, due to safety and efficacy concerns, they are rarely treated with interferon and ribavirin.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9867
|
|
pubmed:author |
pubmed-author:BroersBarbaraB,
pubmed-author:FreiMarkusM,
pubmed-author:FriedRonaldR,
pubmed-author:HeroldMarkusM,
pubmed-author:HuberMiloM,
pubmed-author:IslerMarcM,
pubmed-author:KöllikerChristophC,
pubmed-author:MonnatMartineM,
pubmed-author:OppligerRobertR,
pubmed-author:SchönbucherPeterP,
pubmed-author:SchmidPatrickP,
pubmed-author:SeidenbergAndréA
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
123-30
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19023207-Adult,
pubmed-meshheading:19023207-Aged,
pubmed-meshheading:19023207-Antiviral Agents,
pubmed-meshheading:19023207-Drug Therapy, Combination,
pubmed-meshheading:19023207-Drug Users,
pubmed-meshheading:19023207-Feasibility Studies,
pubmed-meshheading:19023207-Female,
pubmed-meshheading:19023207-Hepatitis C, Chronic,
pubmed-meshheading:19023207-Humans,
pubmed-meshheading:19023207-Interferon-alpha,
pubmed-meshheading:19023207-Male,
pubmed-meshheading:19023207-Middle Aged,
pubmed-meshheading:19023207-Polyethylene Glycols,
pubmed-meshheading:19023207-Recombinant Proteins,
pubmed-meshheading:19023207-Ribavirin,
pubmed-meshheading:19023207-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs.
|
|
pubmed:affiliation |
Gastroenterology and Hepatology, Private Practice, Basel, Switzerland. rfried@hin.ch
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
